Skip to main content

Table 1 Clinicopathologic variables of included ICC patients

From: Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection

Variables

Values (n = 128)

Age (years)

56.19 ± 9.63

Male

70 (54.7)

Tumor size (cm)

5.83 ± 2.85

Number of tumors

 Single

92 (71.9)

 Multiple

36 (28.1)

AJCC tumor stage

 I

34 (26.6)

 II

19 (14.8)

 III

75 (58.6)

Lymph node metastasis

 No

84 (65.6)

 Yes

44 (34.4)

Vascular invasion

 No

77 (60.2)

 Yes

51 (39.8)

Tumor differentiation

 Well to moderate

44 (34.4)

 Poor to undifferentiated

84 (65.6)

ALT (U/L)

49.58 ± 57.93

AST (U/L)

42.51 ± 31.27

CEA (ng/ml)

6.96 ± 15.93

CA19-9 (U/ml)

272.69 ± 318.33

CA242 (U/ml)

75.56 ± 104.66

Neutrophil (109/L)

4.70 ± 1.91

Lymphocyte (109/L)

1.59 ± 0.49

Monocyte (109/L)

0.66 ± 0.87

PLT (109/L)

232.39 ± 97.68

Albumin (g/L)

40.33 ± 4.45

Child-Pugh score

 A

111 (86.7)

 B

17 (13.3)

NLR

3.30 ± 2.16

PLR

156.79 ± 77.66

LMR

3.20 ± 2.46

SII

793.67 ± 695.14

  1. Data are expressed as mean ± standard deviation or n (%)
  2. ICC intrahepatic cholangiocarcinoma, AJCC American Joint Committee on Cancer, ALT alanine aminotransferase, AST aspartate aminotransferase, CEA carcinoembryonic antigen, PLT blood platelet, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, LMR lymphocyte-to-monocyte ratio, SII systemic immune-inflammation index